Pazopanib HCL intermediates manufacturer

Pazopanib HCL intermediates
Tel: +86-311-67591193 sales@dingminpharma.com
News
Your location: Home » News

What are the considerations for Tofacitinib citrate?

Tofacitinib citrate is an oral drug used for treating rheumatoid arthritis. It belongs to a class of drugs called Janus kinase (JAK) inhibitors. JAKs are enzymes (proteins) that regulate chemical signaling pathways that control biologic processes such as blood formation and the immune response that causes the pain, tenderness and swelling of inflammation. JAKs are found in many cells, especially stem cells in bones and joints. Inhibition of JAKs by tofacitinib prevents inflammation and tissue destruction that is associated with the inflammation of rheumatoid arthritis. Tofacitinib was approved in November
Tofacitinib is an oral, small molecule drug used to treat adults with moderately to severely active rheumatoid arthritis (RA) in which methotrexate did not work well. Tofacitinib works by blocking the body’s production of enzymes called Janus kinases (JAKs) and psoriatic arthritis. JAKs play a role in joint inflammation in RA, which can cause pain, swelling, and stiffness.
we are Tofacitinib citrate  manufacturers,If you want to buy Tofacitinib citrate ,pls contact us.

Other Article
PRODUCTS LIST
CONTACT US
Office Address: No.41, Zhaiying South Street, Yuhua District, Shijiazhuang, Hebei Province.China
R&D and Plant Address: JingShi Cooperative Innovation Industrial Park,No.769 Taihang Street,High-tech Zone,Shijiazhuang
Tel: +86-311-67591193
Fax: +86-311-67591193
sales@dingminpharma.com
Online Service×